Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Brain Neoplasms 21Breast Neoplasms 17Neoplasms 7Fatigue 6Colorectal Neoplasms 6Colonic Neoplasms 6Central Nervous System Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Glioma 5Small Cell Lung Carcinoma 4Neurotoxicity Syndromes 4Neoplasm Metastasis 4Glioblastoma 4Rectal Neoplasms 3Radiation Injuries 3Lymphoma 3Hematologic Neoplasms 3Depression 3Breast Neoplasms, Male 3Unspecified Adult Solid Tumor, Protocol Specific 2Prostatic Neoplasms 2Pain 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malnutrition 2Leukemia 2Head and Neck Neoplasms 2Gliosarcoma 2

Interventions

Vincristine 1Therapeutics 1Taxes 1Polymerase Chain Reaction 1Methotrexate 1Mental Status and Dementia Tests 1Leucovorin 1Gene Expression Profiling 1Filgrastim 1Etoposide 1Doxorubicin 1Dactinomycin 1DNA 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Teratoma, Ovarian × Mental Status and Dementia Tests × Clear all
NCT01080521 2018-04-12

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

GOG Foundation

Completed
247 enrolled
Gynecologic

Teratoma, Ovarian, Brenner Tumor, Dysgerminoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡